Home › Glioblastoma › Florida
Pag-aaral pangklinika para sa Glioblastoma sa Florida
30 pag-aaral para sa Glioblastoma ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Miami Cancer Institute, Miami
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07326566A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06914128Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Advent Health, Orlando
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07195591Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Mayo Clinic in Florida, Jacksonville
- at 2 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05432804A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07464925A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Sylvester Comprehensive Cancer Center*, Miami
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT03970447A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
- Mayo Jacksonville, Jacksonville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT05303467A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
- UF Health, Gainesville
Nagre-recruitPhase 1
Edad 4 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT04573140Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
- Mayo Clinic in Florida, Jacksonville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07708961Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- at 6 pa
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06860594Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Jacksonville, Jacksonville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06810544Window of Opportunity Study of Lixumistat in Patients With Newly Diagnosed Glioblastoma
- University of Miami, Miami
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT07884344SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- University of Florida Health, Gainesville
- Mayo Clinic - Florida, Jacksonville
- University of Miami Health, Miami
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05303519Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- Baptist Health Herbert Wertheim Cancer Institute, Miami
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06991101The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07285044Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- MDR Core Network, Boynton Beach
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06047379OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
- UF Health Shands Hospital, Gainesville
Nagre-recruitPhase 2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06558214Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
- University of Miami (Data collection only), Miami
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06934889Targeted Pediatric High-Grade Glioma Therapy
- University of Miami, Miami
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- University of Miami Hospital and Clinics, Miami
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06161974Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial
- Baptist MD Anderson Cancer Center, Jacksonville
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06319027Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Florida, Jacksonville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07091864A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Florida, Jacksonville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07074756Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma
- University of Miami, Miami
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT05284643DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
- Baptist MD Anderson Cancer Center, Jacksonville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06805305A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Jacksonville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 14, 2026 · NCT07185880Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
- Mayo Clinic in Florida, Jacksonville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT05789394Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
- Miami Cancer Institute at Baptist Health, Inc., Miami
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT05756985Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
- Jackson Memorial Hospital, Miami
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 8, 2025 · NCT05956821SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.